In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 11.65 above Vivos Inc average.

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Quick Ratio than Vivos Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 158 to 176.

Explain Quick Ratio?
How much Cash & cash equivalents RDGL�s has?
What are RDGL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RDGL/financial-strength

https://api.csimarket.com/api/v1/companies/RDGL/fundamentals

https://api.csimarket.com/api/v1/companies/RDGL/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

RDGL Quick Ratio	(Sep 30 2026) Q3	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	60.81 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-32.07 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	11.65	Subscribe	Subscribe	Subscribe	Subscribe
RDGL's Total Ranking	# 176	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	8.06 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-28.44 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 3
Healthcare Sector	# 71
Overall Market	# 176

Quick Ratio Statistics
High	Average	Low
28.83	6.66	0
(Mar 31 2023)		(Mar 31 2018)

Financial Statements
Vivos Inc's Current Liabilities	$ 0 Millions	Visit RDGL's Balance sheet
Vivos Inc's Cash & cash equivalent	$ 2 Millions	Visit RDGL's Balance sheet
Source of RDGL's Sales		Visit RDGL's Sales by Geography

Cumulative Vivos Inc's Quick Ratio

RDGL's Quick Ratio for the trailling 12 Months

RDGL Quick Ratio	(Sep 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	45.26 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-13.49 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	16.06	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2216	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	13.18 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-9.54 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to RDGL Financial Strength Comparisons >> Go to Compare RDGL Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $0.16 millions, cumulative Quick Ratio decreased to 16.06 above the RDGL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 153 other companies have achieved higher Quick Ratio than Vivos Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2167 to 2216.

Explain Quick Ratio?
How much Cash & cash equivalents RDGL�s has?
What are RDGL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 154
Healthcare Sector	# 736
Within the Market	# 2216

trailing twelve months Quick Ratio Statistics
High	Average	Low
26.97	7.8	0
(Jun 30 2025)		(Dec 31 2018)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Bone Biologics Corporation	12.66	$ 6.088 Millions	$ 0.481 Millions
Heartflow Inc	12.22	$ 652.533 Millions	$ 53.410 Millions
Vivos Inc	11.65	$ 1.807 Millions	$ 0.155 Millions
Anteris Technologies Global Corp	11.37	$ 216.987 Millions	$ 19.085 Millions
Lemaitre Vascular Inc	11.26	$ 389.721 Millions	$ 34.620 Millions
Mobia Medical Inc	10.63	$ 160.692 Millions	$ 15.115 Millions
Axogen inc	9.55	$ 348.068 Millions	$ 36.456 Millions
Delcath Systems Inc	8.01	$ 104.315 Millions	$ 13.022 Millions
Orchestra Biomed Holdings Inc	7.16	$ 101.907 Millions	$ 14.228 Millions
Envveno Medical Corporation	7.13	$ 18.472 Millions	$ 2.589 Millions
Ceribell Inc	6.51	$ 117.467 Millions	$ 18.034 Millions
Autonomix Medical Inc	6.13	$ 7.692 Millions	$ 1.254 Millions
Iradimed Corporation	6.13	$ 63.288 Millions	$ 10.323 Millions
Orasure Technologies Inc	5.90	$ 148.238 Millions	$ 25.104 Millions
Perspective Therapeutics Inc	5.09	$ 201.695 Millions	$ 39.602 Millions
Clearpoint Neuro Inc	4.68	$ 46.184 Millions	$ 9.869 Millions
Cvrx inc	4.67	$ 58.746 Millions	$ 12.583 Millions
Heartbeam Inc	4.47	$ 6.065 Millions	$ 1.358 Millions
Dexcom Inc	4.25	$ 964.800 Millions	$ 227.000 Millions
Innovative Eyewear Inc	3.86	$ 3.197 Millions	$ 0.829 Millions
Sight Sciences Inc	3.84	$ 77.402 Millions	$ 20.137 Millions
Bluejay Diagnostics Inc	3.83	$ 7.380 Millions	$ 1.927 Millions
Alpha Pro Tech Ltd	3.78	$ 25.546 Millions	$ 6.750 Millions
Hyperfine Inc	3.60	$ 37.872 Millions	$ 10.532 Millions
Capsovision Inc	3.55	$ 21.757 Millions	$ 6.124 Millions
Profound Medical Corp	3.41	$ 33.343 Millions	$ 9.771 Millions
Rxsight Inc	3.40	$ 254.683 Millions	$ 74.952 Millions
Omada Health Inc	3.23	$ 243.151 Millions	$ 75.379 Millions
Transmedics Group Inc	3.22	$ 492.962 Millions	$ 152.857 Millions
Trisalus Life Sciences Inc	3.15	$ 41.057 Millions	$ 13.014 Millions

Date modified: 2026-11-13T05:48:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.